Robinow syndrome with growth hormone deficiency: Treatment with growth hormone

Journal of Pediatric Endocrinology and Metabolism

Volumn 12, Issue 4, 1999, Pages 565-571

  Castells, Salvador ^a,b   Chakurkar, A ^a   Qazi, Q ^a   Bastian, W ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b Box 49 ^*  (United States)

Author keywords

Failure to grow; Recombinant human growth hormone treatment; Robinow syndrome; Scoliosis

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; RECOMBINANT GROWTH HORMONE;

ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DWARFISM; GROWTH HORMONE DEFICIENCY; GROWTH RATE; HUMAN; MALE; ROBINOW SYNDROME; SCOLIOSIS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032781135     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1999.12.4.565     Document Type: Article

References (32)

1. Robinow M, Silverman FN, Smith HD. A newly recognized dwarfism syndrome. Am J Dis Child 1969; 117: 645-651.
2. Kawai M, Yorifuji T, Yamanaka C, Sasaki H, Momoi T, Furusho K. A case of Robinow syndrome accompanied by partial growth hormone insufficiency treated with growth hormone. Horm Res 1997; 48: 41-43.
3. Butler MG, Waddington WB. Robinow syndrome: report of two patients and review of literature. Clin Genet 1987; 31: 77-85.
4. Hanssler H, Schwanitz G. Report on a variant of the fetal face syndrome with acral dysostosis. Klin Paediatr 1975; 187: 274-277.
5. Kelly TE, Benson R, Temtamy S, Plotnick L, Levin S. The Robinow syndrome: an isolated case with a detailed study of the phenotype. Am J Dis Child 1975; 129: 383-386.
6. Khayat D, Schaison G, Frija J, Szpirglas H. Robinow's syndrome, apropos of a case with thrombopenia. Arch Pediatr 1983; 40: 327-330.
7. Israel H, Johnson GF. Craniofacial pattern similarities and additional orofacial findings in siblings with the Robinow syndrome. J Craniofac Genet Dev Biol 1988; 8: 63-73.
8. Marni E, Monfafo V, Zanol MG, Pedroni E. The fetal face syndrome or Robinow syndrome. Description of a case. Minerva Pediatr 1980; 32: 47-52.
9. Vera-Roman JM. Robinow dwarfing syndrome accompanied by penile agenesis and hemivertebrae. Am J Dis Child 1973; 126: 206-208.
10. Portnoy Y. Robinow syndrome. Clin Pediatr 1979; 18: 707-708.
11. Rodriguez Costa T, Garcia De Leon R, Casas Fernandez C, Puche Mira A, Perez-Bryan J. Robinow syndrome: Presentation of a case and review of the literature. An Esp Pediatr 1984; 20: 55-61.
12. Saal HM, Poole AE, Lodiero JG, Weinbaum PJ, Greenstein RM. Autosomal recessive Robinow syndrome: Evidence for genetic heterogeneity. Am J Hum Genet 1985; 37: 74A.
13. Teebi AS. Autosomal recessive Robinow syndrome. Am J Med Genet 1990; 35: 64-68.
14. Bain MD, Winter RM, Burn J. Robinow syndrome without mesomelic "brachymelia": a report of five cases. J Med Genet 1986; 23: 350-354.
15. Wang LY, Hsu CH, Shin SL, Lin SP. Robinow syndrome: report of one case. Chung Hua Min Kuo Hsiao Erh Ko I Hsueh Hui Tsa Chin 1997; 38: 235-238.
16. Kaplan SA. Growth and growth hormone: disorders of the anterior pituitary. In: Clinical Pediatric Endocrinology. Philadelphia, PA: WB Saunders Co., 1990; 1-62.
17. Tanner JM, Davies SW. Clinical longitudinal standards for height and height velocity for North American children. J Pediatr 1985; 107: 317-329.
18. National Center for Health Statistics. NCHS growth curves for children, birth to 18 years (U.S.). Hyattsville, MD: National Center for Health Statistics, 1977.
19. Tanner JM, Landt KW, Cameron N, Carter BS, Patel J. Prediction of adult height from height and bone age in childhood. Arch Dis Child 1983; 58: 767-776.
20. Shalet SM, Toogood A, Rahim A, Brennan B. The diagnosis of growth hormone deficiency in children and adults. Endocr Rev 1998; 19: 203-223.
21. Donnadieu M, Evain-Brion D, Tonon MC, Vaudry H, Job JC. Variations of plasma growth hormone (GH)-releasing factor levels during GH stimulation tests in children. J Clin Endocrinol Metab 1985; 60: 1132-1134.
22. Tapanainen P, Knip M, Lautala P, Leppaluoto J. Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men. J Clin Endocrinol Metab 1988; 67: 845-849.
23. Chihara K, Kashio Y, Kita T, Okimura Y, Kaji H, Abe H, Fujita T. L-Dopa stimulates release of hypothalamic growth hormone-releasing hormone in humans. J Clin Endocrinol Metab 1986; 62: 466-473.
24. Miki N, Ono M, Shizume K. Evidence that opiatergic and alpha-adrenergic mechanisms stimulate rat growth hormone release via growth hormone releasing factor (GRF). Endocrinology 1984; 114: 1950-1952.
25. Pirazzoli P, Cacciari E, Mandini M, Sganga T, Capelli M, Cicognani A, Gualandi S. Growth and thyroid function in children treated with growth hormone. J Pediatr 1992; 121: 210-213.
26. Root AW, Bongiovanni AM, Eberlein WR. Inhibition of thyroidal radioiodine uptake by human growth hormone. J Pediatr 1970; 76: 422-429.
27. Root AW, Snyder PJ, Rezvani I, DiGeorge AM, Utiger RD. Inhibition of thyrotropin-releasing hormone-mediated secretion of thyrotropin by human growth hormone. J Clin Endocrinol Metab 1973; 36: 103-107.
28. Porter BA, Refetoff S, Rosenfield RL, DeGroot LJ, Fang VS, Stark V. Abnormal thyroxine metabolism in hyposomatotrophic dwarfism and inhibition of responsiveness to TRH during GH therapy. Pediatrics 1973; 51: 668-674.
29. Lippe B, Van Herle AJ, LaFranchi SH, Uller RP, Lavin N, Kaplan SA. Reversible hypothyroidism in growth hormone-deficient children treated with human growth hormone. J Clin Endocrinol Metab 1975; 40: 612-618.
30. Sato T, Suzuki Y, Taketani T, Ishiguro K, Masuyama T, Takata I, Sano M, Kawashima H, Koizumi S, Nakajima H. Enhanced peripheral conversion of thyroxine to triiodothyronine during hGH therapy in GH deficient children. J Clin Endocrinol Metab 1977; 45: 324-329.
31. Dymling JF, Willner S. Progression of a structural scoliosis during treatment with growth hormone. A case report. Acta Orthop Scand 1978; 49: 264-268.
32. Allen DB. Safety of human growth hormone therapy: Current topics. J Pediatr 1996; 128: S8-13.